Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 12/20 | 0.58 |
| ▸ | MTNR1B | P49286 | 12/20 | 0.58 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | EED | O75530 | 1/20 | 0.35 |
| ▸ | RBBP4 | Q09028 | 1/20 | 0.35 |
| ▸ | SUZ12 | Q15022 | 1/20 | 0.35 |
| ▸ | AEBP2 | Q6ZN18 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4966587 | 0.90 | MTNR1A (0.69) | MTNR1AMTNR1BMEN1LMNACYP1A2 | |
| SCHEMBL8822760 | 0.83 | MTNR1A (0.60) | MTNR1AMTNR1BMEN1LMNACYP1A2 | |
| SCHEMBL7057879 | 0.82 | MTNR1A (0.65) | MTNR1AMTNR1BMEN1LMNACYP1A2 | |
| SCHEMBL7054082 | 0.81 | MTNR1A (0.66) | MTNR1AMTNR1BMEN1LMNACYP1A2 | |
| SCHEMBL7051614 | 0.80 | MTNR1A (0.65) | MTNR1AMTNR1BMEN1LMNACYP1A2 | |
| SCHEMBL7055066 | 0.79 | MTNR1A (0.54) | MTNR1AMTNR1BMEN1LMNACYP1A2 | |
| SCHEMBL7055344 | 0.79 | MTNR1A (0.54) | MTNR1AMTNR1BTRPV1 | |
| SCHEMBL7051696 | 0.77 | MTNR1A (0.64) | MTNR1AMTNR1BMEN1LMNACYP1A2 | |
| SCHEMBL8822728 | 0.77 | MTNR1A (0.57) | MTNR1AMTNR1BMEN1LMNACYP1A2 | |
| SCHEMBL7050446 | 0.76 | MTNR1A (0.52) | MTNR1AMTNR1BMEN1LMNACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0656209-B1 | Melatonin derivatives for use in treating desynchronization disorders | LILLY CO ELI (US) | 2003-05-07 | — | — | EP | disclosed |
| CN-1100533-C | Melatonin derivatives for use in terating desynchronization disorders | LILLY CO ELI (US) | 2003-02-05 | — | — | CN | disclosed |
| CN-1092958-C | Melatonin derivatives for use in treating sleep disorders | LILLY CO ELI (US) | 2002-10-23 | — | — | CN | disclosed |
| EP-0655243-B1 | Melatonin derivatives for use in treating sleep disorders | LILLY CO ELI (US) | 2002-08-21 | — | — | EP | disclosed |
| US-6180657-B1 | SLEEP DISORDERS | ELI LILLY AND COMPANY | 2001-01-30 | — | — | US | disclosed |
| CN-1191484-A | Melatonin agonists for treating benign prostatic hyperplasia | LILLY CO ELI (US) | 1998-08-26 | — | — | CN | disclosed |
| US-5770610-A | ADMINISTERING R-(+)-N-(2-METHYL-2-(5-METHOXY-6-CHLOROINDOL-3-YL)ETHYL) ACETAMIDE | ELI LILLY AND COMPANY (US) | 1998-06-23 | — | — | US | disclosed |
| US-5654325-A | Melatonin derivatives for use in treating sleep disorders | ELI LILLY AND COMPANY (US) | 1997-08-05 | — | — | US | disclosed |
| WO-1997000069-A1 | MELATONIN AGONISTS FOR TREATING BENIGN PROSTATIC HYPERPLASIA | ELI LILLY AND COMPANY (US) | 1997-01-03 | — | — | WO | disclosed |
| EP-0748627-A2 | Melatonin agonists for use in the treatment of benign prostatic hyperplasia | ELI LILLY AND COMPANY (US) | 1996-12-18 | — | — | EP | disclosed |
| CN-1107700-A | Melatonin derivatives for use in terating desynchronization disorders | LILLY CO ELI (US) | 1995-09-06 | — | — | CN | disclosed |
| CN-1107701-A | Melatonin derivatives for use in treating sleep disorders | LILLY CO ELI (US) | 1995-09-06 | — | — | CN | disclosed |
| EP-0656209-A2 | Melatonin derivatives for use in treating desynchronization disorders | ELI LILLY AND COMPANY (US) | 1995-06-07 | — | — | EP | disclosed |
| EP-0655243-A2 | Melatonin derivatives for use in treating sleep disorders | ELI LILLY AND COMPANY (US) | 1995-05-31 | — | — | EP | disclosed |